1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Industry in the United States Market Research & Statistics

Biological Therapy Industry in the United States Market Research & Statistics

24/7 Customer Support

Talk to Sam

+1 718 473 0872

All regions

About 1 800 reports

Download Unlimited Documents from Trusted Public Sources

Biological Therapy Industry in the US

  • June 2016
    20 pages
  • Antisense  

    Antisense RNA  

    Antisense Techn...  

  • United States  

View report >

Biological Therapy Industry in the US

  • May 2016
    16 pages
  • Biological Ther...  

    Cytokine  

  • United States  

View report >

Biological Therapy Industry in the US

  • May 2016
    8 pages
  • Biological Ther...  

  • United States  

View report >

Biological Therapy Industry in the US - Forecast

  • May 2016
    24 pages
  • Cancer  

  • United States  

    New Caledonia  

View report >

Biological Therapy Industry in the US

  • May 2016
    10 pages
  • Biological Ther...  

    In Vitro Diagno...  

  • United States  

View report >

Biological Therapy Industry in the US

  • May 2016
    10 pages
  • Cytokine  

    Gene Therapy  

    Cell Therapy  

  • United States  

View report >

Biological Therapy Industry in the US

  • May 2016
    10 pages
  • Biological Ther...  

  • United States  

View report >

Biological Therapy Industry in the US

  • May 2016
    10 pages
  • Biological Ther...  

  • United States  

View report >

Biological Therapy Industry in the US

  • May 2016
    9 pages
  • Biological Ther...  

    Biotechnology  

  • United States  

View report >

Biological Therapy Industry in the US

  • May 2016
    10 pages
  • Biological Ther...  

  • United States  

View report >


About 400 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 99 - $ 3 500)

Nicotinamide Phosphoribosyl Transferase (NAmPRTase or Pre-B-Cell Colony-Enhancing Factor 1 or EC 2.4.2.12) - Pipeline Review, H1 2016

Nicotinamide Phosphoribosyl Transferase (NAmPRTase or Pre-B-Cell Colony-Enhancing Factor 1 or EC 2.4.2.12) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • May 2016
  • by Global Markets Direct

Nicotinamide Phosphoribosyl Transferase (NAmPRTase or Pre-B-Cell Colony-Enhancing Factor 1 or EC 2.4.2.12) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Nicotinamide Phosphoribosyl Transferase ...

Connective Tissue Growth Factor (insulin-like Growth Fa ...

April 2016 $ 3 500

Huntingtin (huntington Disease Protein) - Pipeline Revi ...

April 2016 $ 3 500

Global Gene Therapy Partnering Terms And Agreements 201 ...

June 2016 $ 2 995

Nucleus Replacement - Medical Devices Pipeline Assessme ...

June 2016 $ 2 500

Global Regenerative Medicine Market 2016-2020

May 2016 $ 2 500

Global Cancer Immunotherapies Market 2016-2020

April 2016 $ 2 500

Myelodysplastic Syndrome Global Clinical Trials Review, ...

March 2016 $ 2 500

Cytomegalovirus (hhv-5) Infections - Pipeline Review, H ...

May 2016 $ 2 000

Hemophilia A - Pipeline Review, H1 2016

May 2016 $ 2 000

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.